D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering
HWH International Inc. is a purpose-driven lifestyle company encompassing differentiated offerings from four core pillars: Hapi Marketplace, Hapi Cafe, Hapi Travel and Hapi Wealth Builder. The Company ...
Hosted on MSN13h
D. Boral Capital Initiates Coverage of Nano-X Imaging (NNOX) with Buy Recommendation
Fintel reports that on January 6, 2025, D. Boral Capital initiated coverage of Nano-X Imaging (NasdaqGM:NNOX) with a Buy ...
Nano-X Imaging initiated with a Buy at D. Boral Capital
D. Boral Capital analyst Jason Kolbert initiated coverage of Nano-X Imaging (NNOX) with a Buy rating and $23 price target Nanox is at the ...
CytoSorbents reported strong Q4 results, says D. Boral Capital
D. Boral Capital says CytoSorbents (CTSO) reported a strong Q4, with product revenue growth estimated between 22% and 25% ...
Nano-X Imaging (NASDAQ:NNOX) Coverage Initiated by Analysts at D. Boral Capital
Equities research analysts at D. Boral Capital initiated coverage on shares of Nano-X Imaging (NASDAQ:NNOX – Get Free Report) in a research report issued to clients and investors on Monday,Benzinga ...
Lineage Cell price target lowered to $2 from $3 at D. Boral Capital
D. Boral Capital lowered the firm’s price target on Lineage Cell Therapeutics (LCTX) to $2 from $3 and keeps a Buy rating on ...
Fintel on MSN14d
D. Boral Capital Initiates Coverage of Omeros (OMER) with Buy Recommendation
Fintel reports that on December 23, 2024, D. Boral Capital initiated coverage of Omeros (NasdaqGM:OMER) with a Buy ...
ImmunityBio (NASDAQ:IBRX) Earns Buy Rating from D. Boral Capital
ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at D. Boral Capital in a ...
Boral Capital将Nano-X Imaging股票评级设为买入，看好其创新
周一，Boral Capital对Nano-X Imaging（NASDAQ:NNOX）股票启动覆盖，给予买入评级，目标价为$23.00。该公司分析师强调了Nano-X在医学影像领域的创新方法，突出其Nanox.ARC技术在该领域的革命性作用。
manilatimes26d
D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering
BTIG and H.C. Wainwright & Co. are acting as co-lead managers with D. Boral Capital acting as co-manager for the offering. This press release shall not constitute an offer to sell or the solicitation ...
The Armenian Reporter2d
U.S. Energy (NASDAQ:USEG) Receives Buy Rating from D. Boral Capital
U.S. Energy (NASDAQ:USEG – Get Free Report)‘s stock had its “buy” rating reissued by D. Boral Capital in a note issued to investors on Friday,Benzinga reports. They currently have a $2.00 price target ...
Citius股票评级上调至买入，Boral Capital设定目标价
周一，Boral Capital将Citius Pharmaceuticals (NASDAQ: CTXR)的股票评级从持有上调至买入，并设定9.00美元的目标价。此次上调反映了Boral Capital估值模型的调整，现在考虑了拆股和公司Mino-Lok产品预期批准时间表的修订。根据InvestingPro数据，该股在过去一周表现出强劲势头，上涨26.46%，但仍远低于52周高点26.75美元。